“…These DCs are generically termed regulatory DCs and include very diverse myeloid subsets of different origins and activities. Although the abundance and phenotype of regulatory DCs reported in different tumors varies, immunosuppressive attributes have been associated with DCs representing the major DC subsets in mice and humans: Plasmacytoid, conventional and inflammatory DCs (Bachem, et al, 2010; Haniffa, et al, 2012; Manh, Alexandre, Baranek, Crozat, & Dalod, 2013; Merad, Sathe, Helft, Miller, & Mortha, 2013; Segura & Amigorena, 2013, 2014; Segura, et al, 2013). …”